[HTML][HTML] The CAPRA score versus sub-types of minimal residual disease to predict biochemical failure after external beam radiotherapy
NP Murray, S Aedo, C Fuentealba, E Reyes… - …, 2020 - ncbi.nlm.nih.gov
Results 309 men participated with a median follow-up of 8 years. The risk of biochemical
failure increased proportionally with increasing CAPRA score, hazard ratio 1.18 for …
failure increased proportionally with increasing CAPRA score, hazard ratio 1.18 for …
The CAPRA score versus sub-types of minimal residual disease to predict biochemical failure after external beam radiotherapy
NP Murray, S Aedo, C Fuentealba… - …, 2020 - pubmed.ncbi.nlm.nih.gov
Introduction External beam radiotherapy is a treatment option for clinically localised prostate
cancer; however, some 15% of patients will undergo treatment failure within 5 years. The …
cancer; however, some 15% of patients will undergo treatment failure within 5 years. The …
[PDF][PDF] The CAPRA score versus sub-types of minimal residual disease to predict biochemical failure after external beam radiotherapy
NP Murray, S Aedo, C Fuentealba, E Reyes, A Salazar… - medfinis.cl
Introduction: External beam radiotherapy is a treatment option for clinically localised prostate
cancer; however, some 15% of patients will undergo treatment failure within 5 years. The …
cancer; however, some 15% of patients will undergo treatment failure within 5 years. The …
The CAPRA score versus sub-types of minimal residual disease to predict biochemical failure after external beam radiotherapy.
NP Murray, S Aedo, C Fuentealba, E Reyes… - …, 2020 - europepmc.org
Results 309 men participated with a median follow-up of 8 years. The risk of biochemical
failure increased proportionally with increasing CAPRA score, hazard ratio 1.18 for …
failure increased proportionally with increasing CAPRA score, hazard ratio 1.18 for …
[PDF][PDF] The CAPRA score versus sub-types of minimal residual disease to predict biochemical failure after external beam radiotherapy
NP Murray, S Aedo, C Fuentealba, E Reyes, A Salazar… - academia.edu
Introduction: External beam radiotherapy is a treatment option for clinically localised prostate
cancer; however, some 15% of patients will undergo treatment failure within 5 years. The …
cancer; however, some 15% of patients will undergo treatment failure within 5 years. The …
[PDF][PDF] The CAPRA score versus sub-types of minimal residual disease to predict biochemical failure after external beam radiotherapy
NP Murray, S Aedo, C Fuentealba, E Reyes, A Salazar… - medfinis.cl
Introduction: External beam radiotherapy is a treatment option for clinically localised prostate
cancer; however, some 15% of patients will undergo treatment failure within 5 years. The …
cancer; however, some 15% of patients will undergo treatment failure within 5 years. The …
[HTML][HTML] The CAPRA score versus sub-types of minimal residual disease to predict biochemical failure after external beam radiotherapy
NP Murray, S Aedo, C Fuentealba, E Reyes, A Salazar… - 2020 - ecancer.org
Introduction: External beam radiotherapy is a treatment option for clinically localised prostate
cancer; however, some 15% of patients will undergo treatment failure within 5 years. The …
cancer; however, some 15% of patients will undergo treatment failure within 5 years. The …
The CAPRA score versus sub-types of minimal residual disease to predict biochemical failure after external beam radiotherapy
NP Murray, A Socrates, C Fuentealba… - …, 2020 - search.proquest.com
Results 309 men participated with a median follow-up of 8 years. The risk of biochemical
failure increased proportionally with increasing CAPRA score, hazard ratio 1.18 for …
failure increased proportionally with increasing CAPRA score, hazard ratio 1.18 for …
[HTML][HTML] The CAPRA score versus sub-types of minimal residual disease to predict biochemical failure after external beam radiotherapy
NP Murray, S Aedo, C Fuentealba, E Reyes, A Salazar… - 2020 - ecancer.org
Introduction: External beam radiotherapy is a treatment option for clinically localised prostate
cancer; however, some 15% of patients will undergo treatment failure within 5 years. The …
cancer; however, some 15% of patients will undergo treatment failure within 5 years. The …
[PDF][PDF] The CAPRA score versus sub-types of minimal residual disease to predict biochemical failure after external beam radiotherapy
NP Murray, S Aedo, C Fuentealba, E Reyes, A Salazar… - medfinis.cl
Introduction: External beam radiotherapy is a treatment option for clinically localised prostate
cancer; however, some 15% of patients will undergo treatment failure within 5 years. The …
cancer; however, some 15% of patients will undergo treatment failure within 5 years. The …